Profile

Scott Nicholas Furlan, MD

Scott Nicholas Furlan, MD

Hematology-Oncology

On staff since December 2015

Academic Title: Acting Instructor

"I am driven to improve the therapy of cancer and blood disorders in children not only with thoughtful research, but also by accompanying patients and their families through the daily triumphs and struggles of their journey, one-by-one."

    • Furlan SN, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, Singh K, Giver C, Hamby K, Stempora L, Garrett A, Chen J, Betz KM, Ziegler CG, Tharp GK, Bosinger SE, Promislow DE, Miller JS, Waller EK, Blazar BR, Kean LS
      Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
      26606970 Science translational medicine , 2015 Nov. 25 - 2015 Nov. 25 : 7(315)315ra191
    • Furlan SN, Mandraju R, Brewer T, Roybal K, Troutman TD, Hu W, Palm NW, Unni A, Pasare C
      Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.
      24284965 mAbs , 2014 Jan. - 2014 Jan. : 6(1)108-18 PMCID: PMC3929435

Overview

Board Certification(s)

Pediatrics
Pediatric Hematology-Oncology

Medical/Professional School

Keck School of Medicine at USC, Los Angeles

Residency

Pediatrics, UT Southwestern Medical School, Dallas

Fellowship

Pediatric Hematology-Oncology, UT Southwestern Medical Center, Dallas
Seattle Children's Research Institute, Seattle

Clinical Interests

Hematopoietic cell transplantation, graft-versus-host disease, transplant immunology, cellular therapies

Research Description

Genomics, immunology, molecular biology